Raj Haribhakti

Raj is currently a Pharm Sci Team Leader in the Bio Therapeutics, division of Pharmaceutical Sciences at Pfizer, since 2019. He has worked in Drug Development for over 30 years having global and domestic experience in leading drug development projects and teams, from early development through clinical development. Prior to joining Pfizer, Raj has had various roles at Sanofi for15 years, and at Janssen (J&J) and Takeda also as Pharm Sciences team leader. Raj has been recognized for achieving high quality results in multi-faceted environments, culminating in several successful FDA drug approvals for new indications on several medicines as well as life cycle extensions for key products. Raj has extensive CMC and clinical project management expertise. As part of his current role, Raj has led multiple projects through China submissions and played a key role in helping project teams lead negotiations/justifications with China Health Authority on how China development timelines integrate with global development to enable simultaneous market authorization targets for programs. Raj has graduate and undergraduate degrees in Pharmaceutical Sciences.


This speaker has made no appearances.